These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19284741)

  • 21. Differential effects of NMDA and AMPA/kainate receptor antagonists on nitric oxide production in rat brain following intrahippocampal injection.
    Radenovic L; Selakovic V
    Brain Res Bull; 2005 Sep; 67(1-2):133-41. PubMed ID: 16140172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probing the function, conformational plasticity, and dimer-dimer contacts of the GluR2 ligand-binding core: studies of 5-substituted willardiines and GluR2 S1S2 in the crystal.
    Jin R; Gouaux E
    Biochemistry; 2003 May; 42(18):5201-13. PubMed ID: 12731861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-based rational design of chemical ligands for AMPA-subtype glutamate receptors.
    Zeng L; Chen CH; Muller M; Zhou MM
    J Mol Neurosci; 2003; 20(3):345-8. PubMed ID: 14501018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding of the new radioligand (S)-[3H]AMPA to rat brain synaptic membranes: effects of a series of structural analogues of the non-NMDA receptor agonist willardiine.
    Hawkins LM; Beaver KM; Jane DE; Taylor PM; Sunter DC; Roberts PJ
    Neuropharmacology; 1995 Apr; 34(4):405-10. PubMed ID: 7566471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Competitive antagonism of AMPA receptors by ligands of different classes: crystal structure of ATPO bound to the GluR2 ligand-binding core, in comparison with DNQX.
    Hogner A; Greenwood JR; Liljefors T; Lunn ML; Egebjerg J; Larsen IK; Gouaux E; Kastrup JS
    J Med Chem; 2003 Jan; 46(2):214-21. PubMed ID: 12519060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural mobility of the extracellular ligand-binding core of an ionotropic glutamate receptor. Analysis of NMR relaxation dynamics.
    McFeeters RL; Oswald RE
    Biochemistry; 2002 Aug; 41(33):10472-81. PubMed ID: 12173934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Excitatory amino acid receptor ligands: resolution, absolute stereochemistry, and enantiopharmacology of 2-amino-3-(4-butyl-3-hydroxyisoxazol-5-yl)propionic acid.
    Johansen TN; Ebert B; Bräuner-Osborne H; Didriksen M; Christensen IT; Søby KK; Madsen U; Krogsgaard-Larsen P; Brehm L
    J Med Chem; 1998 Mar; 41(6):930-9. PubMed ID: 9526567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A quantum biochemistry investigation of willardiine partial agonism in AMPA receptors.
    Lima Neto JX; Fulco UL; Albuquerque EL; Corso G; Bezerra EM; Caetano EW; da Costa RF; Freire VN
    Phys Chem Chem Phys; 2015 May; 17(19):13092-103. PubMed ID: 25915595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-activity relationship studies on N3-substituted willardiine derivatives acting as AMPA or kainate receptor antagonists.
    Dolman NP; More JC; Alt A; Knauss JL; Troop HM; Bleakman D; Collingridge GL; Jane DE
    J Med Chem; 2006 Apr; 49(8):2579-92. PubMed ID: 16610801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tyr702 is an important determinant of agonist binding and domain closure of the ligand-binding core of GluR2.
    Frandsen A; Pickering DS; Vestergaard B; Kasper C; Nielsen BB; Greenwood JR; Campiani G; Fattorusso C; Gajhede M; Schousboe A; Kastrup JS
    Mol Pharmacol; 2005 Mar; 67(3):703-13. PubMed ID: 15591246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discrimination between agonists and antagonists by the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid-selective glutamate receptor. A mutation analysis of the ligand-binding domain of GluR-D subunit.
    Lampinen M; Settimo L; Pentikainen OT; Jouppila A; Mottershead DG; Johnson MS; Keinanen K
    J Biol Chem; 2002 Nov; 277(44):41940-7. PubMed ID: 12167621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The biochemistry, ultrastructure, and subunit assembly mechanism of AMPA receptors.
    Nakagawa T
    Mol Neurobiol; 2010 Dec; 42(3):161-84. PubMed ID: 21080238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation and desensitization of AMPA/kainate receptors by novel derivatives of willardiine.
    Patneau DK; Mayer ML; Jane DE; Watkins JC
    J Neurosci; 1992 Feb; 12(2):595-606. PubMed ID: 1371315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lead-Induced ERK Activation Is Mediated by GluR2 Non-containing AMPA Receptor in Cortical Neurons.
    Ishida K; Kotake Y; Sanoh S; Ohta S
    Biol Pharm Bull; 2017; 40(3):303-309. PubMed ID: 28250271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CNQX increases GABA-mediated synaptic transmission in the cerebellum by an AMPA/kainate receptor-independent mechanism.
    Brickley SG; Farrant M; Swanson GT; Cull-Candy SG
    Neuropharmacology; 2001 Nov; 41(6):730-6. PubMed ID: 11640927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamics of the S1S2 glutamate binding domain of GluR2 measured using 19F NMR spectroscopy.
    Ahmed AH; Loh AP; Jane DE; Oswald RE
    J Biol Chem; 2007 Apr; 282(17):12773-84. PubMed ID: 17337449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 6-Azido-7-nitro-1,4-dihydroquinoxaline-2,3-dione (ANQX) forms an irreversible bond to the active site of the GluR2 AMPA receptor.
    Cruz LA; Estébanez-Perpiñá E; Pfaff S; Borngraeber S; Bao N; Blethrow J; Fletterick RJ; England PM
    J Med Chem; 2008 Sep; 51(18):5856-60. PubMed ID: 18754610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new pyrrolyl-quinoxalinedione series of non-NMDA glutamate receptor antagonists: pharmacological characterization and comparison with NBQX and valproate in the kindling model of epilepsy.
    Löscher W; Lehmann H; Behl B; Seemann D; Teschendorf HJ; Hofmann HP; Lubisch W; Höger T; Lemaire HG; Gross G
    Eur J Neurosci; 1999 Jan; 11(1):250-62. PubMed ID: 9987029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural basis for AMPA receptor activation and ligand selectivity: crystal structures of five agonist complexes with the GluR2 ligand-binding core.
    Hogner A; Kastrup JS; Jin R; Liljefors T; Mayer ML; Egebjerg J; Larsen IK; Gouaux E
    J Mol Biol; 2002 Sep; 322(1):93-109. PubMed ID: 12215417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of inhibition of the GluR2 AMPA receptor channel opening by 2,3-benzodiazepine derivatives.
    Ritz M; Micale N; Grasso S; Niu L
    Biochemistry; 2008 Jan; 47(3):1061-9. PubMed ID: 18161947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.